{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT04704713","recordId":"NCT04704713","peptideSlug":"afamelanotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04704713-afamelanotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04704713.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04704713.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":["Adverse Events","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2021-02-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"afamelanotide","submittedDate":"2021-02-25","publishedAt":"2026-08-23","recordId":"NCT04704713","recordSha256":"b08a52c8a77ad738cd68a241638d1771b227038f0a3fd8825cff54fd81d9b7f1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04704713?a=2&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"959978f80f3e36a294ab48fd69c4215748bb9e97878afbcfd3e298b9201acfcb"}}